Q: What percent of HIV+ individuals in the U.S. have chronic HCV infection?
According to Carol Brosgart, VP of GILD (and former head of GILD’s clinical development), the answer is 40%. (Source: Today’s HCV webcast at the Sanford Bernstein conference)
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”